Why the study?
Few dosimetric comparisons have been published between linear accelerator-based systems and CyberKnife-based robotic radiosurgery systems for cardiac radioablation in ventricular tachycardia.
Does CyberKnife-based robotic radiosurgery provide dosimetric advantages compared to linear accelerator-based systems for noninvasive cardiac radio-ablation in ventricular tachycardia?
Does CyberKnife-based robotic radiosurgery provide dosimetric advantages compared to linear accelerator-based systems for noninvasive cardiac radio-ablation in ventricular tachycardia?
Both CyberKnife and linear accelerator systems provide appropriate dose coverage for noninvasive cardiac radio-ablation, with CyberKnife offering better dose gradients for smaller or spherical targets at the cost of longer treatment times.
Answers are grounded in this paper and cite their sources.
Both systems achieve adequate VT radioablation dosimetry; leaves open whether CK gradient advantages affect clinical outcomes.
Background Few dosimetric comparisons have been published between linear accelerator (LA)-based systems and CyberKnife (CK)-based robotic radiosurgery systems for cardiac radio-ablation in ventricular tachycardia. This study aimed to compare the dosimetry of noninvasive cardiac radio-ablation deliverable on LA with that on CK. Methods Thirteen patients who underwent noninvasive cardiac radio-ablation by LA were included. The prescribed dose was 25 Gy in 1 fraction, and the average planning target volume was 49.8 ± 31.0 cm 3 (range, 14.4–93.7 cm 3 ). CK plans were generated for comparison. Results Both the CK and LA plans accomplished appropriate dose coverage and normal tissue sparing. Compared with the LA plans, the CK plans achieved significantly lower gradient indices (3.12 ± 0.71 vs. 3.48 ± 0.55, p = 0.031) and gradient measures (1.00 ± 0.29 cm vs. 1.17 ± 0.29 cm, p < 0.001). They had similar equivalent conformity indices (CK vs. LA: 0.84 ± 0.08 vs. 0.87 ± 0.07, p = 0.093) and maximum doses 2 cm from the planning target volume (PTV) in any direction (CK vs. LA: 50.8 ± 9.9% vs. 53.1 ± 5.3%, p = 0.423). The dosimetric advantages of CK were more prominent in patients with a PTV of ≤ 50 cm 3 or a spherical PTV. In patients with a PTV of > 50 cm 3 or a non-spherical PTV, the LA and CK plans were similar regarding dosimetric parameters. CK plans involved more beams (232.2 ± 110.8 beams vs. 10.0 ± 1.7 arcs) and longer treatment times (119.2 ± 43.3 min vs. 22.4 ± 1.6 min, p = 0.007). Conclusions Both CK and LA are ideal modalities for noninvasive cardiac radio-ablation. Upfront treatment should be considered based on clinical intent.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: